Bioinformatics, Pharmacokinetics and Small Molecule

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioinformatics

Pharmacokinetics

Small Molecule

Biochemical assays and deep cyclic inhibition in cancer treatment

Drug Target Review

JULY 12, 2023

Once a new drug target is identified, a proprietary deep learning artificial intelligence (AI) platform we call Fluency can rapidly identify small molecules that selectively bind to a target of interest. Our assays and bioinformatics modelling can help identify certain indications that are appropriate for DCI while ruling others out.

Biochemical Assays

Biochemical Assays Treatment Bioinformatics Disease

AI in Drug Discovery - A Highly Opinionated Literature Review (Part II)

Practical Cheminformatics

JANUARY 8, 2024

A Tutorial on Encoding and Generating Small Molecules with COATI [link] COATI: multi-modal contrastive pre-training for representing and traversing chemical space [link] The team at AstraZeneca released version 4 of their software package REINVENT for generative design. Drug discovery is inherently an MPO problem.

Drugs

Drugs Small Molecule Bioinformatics Packaging

Drug Discovery Digest

Biochemical assays and deep cyclic inhibition in cancer treatment

AI in Drug Discovery - A Highly Opinionated Literature Review (Part II)

Stay Connected